Risk-Specific Optimal Cancer Screening Schedules: An Application to Breast Cancer Early Detection

The optimal schedules for breast cancer screening in terms of examination frequency and ages at examination are of practical interest. A decision-theoretic approach is explored to search for optimal cancer screening programs which should achieve maximum survival benefit while balancing the associated cost to the health care system. We propose a class of utility functions that account for costs associated with screening examinations and value of survival benefit under a non-stable disease model. We consider two different optimization criteria: optimize the number of screening examinations with equal screening intervals between exams but without a prefixed total cost; and optimize the ages at which screening should be given for a fixed total cost. We show that an optimal solution exists under each of the two frameworks. The proposed methods may consider women at different levels of risk for breast cancer so that the optimal screening strategies will be tailored according to a woman’s risk of developing the disease. Results of a numerical study are presented and the proposed models are illustrated with various data inputs. We also use the data inputs from the Health Insurance Plan of New York (HIP) and Canadian National Breast Screening Study (CNBSS) to illustrate the proposed models and to compare the utility values between the optimal schedules and the actual schedules in the HIP and CNBSS trials. Here, the utility is defined as the difference in cure rates between cases found at screening examinations and cases found between screening examinations while accounting for the cost of examinations, under a given screening schedule.

[1]  W. Rudin Principles of mathematical analysis , 1964 .

[2]  N. Day,et al.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. , 1984, Biometrics.

[3]  P. Saigo,et al.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A D Tsodikov,et al.  On the optimal policies of cancer screening. , 1991, Mathematical biosciences.

[5]  Giovanni Parmigiani,et al.  On Optimal Screening Ages , 1993 .

[6]  Marvin Zelen,et al.  Optimal scheduling of examinations for the early detection of disease , 1993 .

[7]  Marvin Zelen,et al.  Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer , 1998 .

[8]  M. Zelen,et al.  Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding , 1999 .

[9]  H. Goodare,et al.  NHS breast screening programme , 1999, BMJ.

[10]  M Zelen,et al.  Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Peter Muennig,et al.  Benefits and costs of interventions to improve breast cancer outcomes in African American women. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Sylvia Plevritis,et al.  Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups , 2004, Statistical methods in medical research.

[13]  Giovanni Parmigiani,et al.  A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations , 2005, Cancer Epidemiology Biomarkers & Prevention.

[14]  Maureen A Smith,et al.  Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.

[15]  G. Gazelle,et al.  Use of modeling to evaluate the cost-effectiveness of cancer screening programs. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[17]  Marvin Zelen,et al.  Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms , 2009 .

[18]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.